Vivace Therapeutics

Vivace Therapeutics is a clinical-stage, oncology-focused biotechnology company based in the San Francisco Bay Area, developing small-molecule cancer therapeutics that target the Hippo-YAP signaling pathway. Its lead candidate, VT3989, is in clinical trials for mesothelioma and other solid tumors. The company was surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network. As a private therapeutics developer, Vivace publishes clinical-trial, scientific-publication, and corporate content, but exposes no public developer portal, API, SDK, documentation, or code repositories.

Vivace Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Healthcare.

🌐 Visit website 📡 Source on GitHub
5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsOncologyHealthcareLife SciencesClinical Trials

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 5.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vivace-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: vivace-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/vivace-therapeutics.png
name: Vivace Therapeutics
description: Vivace Therapeutics is a clinical-stage, oncology-focused biotechnology company based in the San Francisco Bay
  Area, developing small-molecule cancer therapeutics that target the Hippo-YAP signaling pathway. Its lead candidate, VT3989,
  is in clinical trials for mesothelioma and other solid tumors. The company was surfaced as a portfolio company of Canaan
  Partners and added to the API Evangelist network. As a private therapeutics developer, Vivace publishes clinical-trial,
  scientific-publication, and corporate content, but exposes no public developer portal, API, SDK, documentation, or code
  repositories.
url: https://raw.githubusercontent.com/api-evangelist/vivace-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Healthcare
- Life Sciences
- Clinical Trials
apis: []
common:
- type: Website
  url: https://vivacetherapeutics.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1